Shopping Cart 0
Cart Subtotal
AED 0

North America Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 10276

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 14313

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 18350

Details

North America genome sequencing market is projected to grow by 11.5% annually in the forecast period and reach USD 10.77 billion by 2030, driven by the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine.

Highlighted with 23 tables and 49 figures, this 103-page report North America Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America genome sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America genome sequencing market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country.

 

Based on Product, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2019-2030 included in each section.

Consumables

Sequencers & Software

Service

 

Based on Technology, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2019-2030 included in each section.

Polymerase Chain Reaction (PCR)

Sequencing

Microarray

Nucleic Acid Extraction and Purification

Other Technologies

 

Based on Application, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2019-2030 included in each section.

Diagnostics

o Oncology

o Reproductive Health

o Complex Disease Research

o Other Diagnostics

Drug Discovery and Development

Precision Medicine

Agriculture and Animal Research

Other Applications

 

By End User, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2019-2030 included in each section.

Academic & Research Centers

Pharmaceutical and Biotechnology Companies

Consumer Genomic Service Providers

Government Institutes

Other End Users

 

Geographically, the following national/local markets are fully investigated:

U.S.

Canada

Mexico

For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2019-2030. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included.

 

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

BGI

Biomatters

Bio-Rad Laboratories, Inc.

DNASTAR

F. Hoffmann-La Roche

Illumina, Inc.

Macrogen Inc.

Myriad Genetics, Inc.

New England Biolabs

Oxford Nanopore Technology

PerkinElmer Inc.

Qiagen

Siemens Healthineers

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Table Of Content

Scope

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 13

1.2.6 Market Size/Share Estimation 14

1.2.7 Research Limitations 15

1.3 Executive Summary 16

2 Market Overview and Dynamics 19

2.1 Market Size and Forecast 19

2.1.1 Impact of COVID-19 on World Economy 20

2.1.2 Impact of COVID-19 on the Market 23

2.2 Major Growth Drivers 25

2.3 Market Restraints and Challenges 32

2.4 Emerging Opportunities and Market Trends 35

2.5 Porter's Fiver Forces Analysis 39

3 Segmentation of North America Market by Product 43

3.1 Market Overview by Product 43

3.2 Consumables 45

3.3 Sequencers & Software 46

3.4 Service 47

4 Segmentation of North America Market by Technology 48

4.1 Market Overview by Technology 48

4.2 Polymerase Chain Reaction (PCR) 50

4.3 Sequencing 51

4.4 Microarray 52

4.5 Nucleic Acid Extraction and Purification 53

4.6 Other Technologies 54

5 Segmentation of North America Market by Application 55

5.1 Market Overview by Application 55

5.2 Diagnostics 57

5.2.1 Oncology 59

5.2.2 Reproductive Health 60

5.2.3 Complex Disease Research 61

5.2.4 Other Diagnostics 62

5.3 Drug Discovery and Development 63

5.4 Precision Medicine 64

5.5 Agriculture and Animal Research 65

5.6 Other Applications 66

6 Segmentation of North America Market by End User 67

6.1 Market Overview by End User 67

6.2 Academic & Research Centers 69

6.3 Pharmaceutical and Biotechnology Companies 70

6.4 Consumer Genomic Service Providers 71

6.5 Government Institutes 72

6.6 Other End Users 73

7 North America Market 2019-2030 by Country 74

7.1 Overview of North America Market 74

7.2 U.S. 77

7.3 Canada 80

7.4 Mexico 82

8 Competitive Landscape 84

8.1 Overview of Key Vendors 84

8.2 New Product Launch, Partnership, Investment, and M&A 87

8.3 Company Profiles 88

BGI 88

Biomatters 90

Bio-Rad Laboratories, Inc. 91

DNASTAR 92

F. Hoffmann-La Roche 93

Illumina, Inc. 94

Macrogen Inc. 95

Myriad Genetics, Inc. 96

New England Biolabs 97

Oxford Nanopore Technology 98

PerkinElmer Inc. 99

Qiagen 100

Siemens Healthineers 101

Thermo Fisher Scientific 102

RELATED REPORTS 103


List Of Figure

List of Figures:

 

Figure 1. Research Method Flow Chart 11

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14

Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16

Figure 4. North America Genome Sequencing Market, 2019-2030, USD mn 19

Figure 5. Impact of COVID-19 on Business 23

Figure 6. Primary Drivers and Impact Factors of North America Genome Sequencing Market 25

Figure 7. World Number of Deaths by Cause in 2017 28

Figure 8. World Number of Deaths from Cancers in 2017 29

Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30

Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 30

Figure 11. Primary Restraints and Impact Factors of North America Genome Sequencing Market 32

Figure 12. Investment Opportunity Analysis 36

Figure 13. Porter's Fiver Forces Analysis of North America Genome Sequencing Market 39

Figure 14. Breakdown of North America Genome Sequencing Market by Product, 2019-2030, % of Revenue 44

Figure 15. North America Addressable Market Cap in 2021-2030 by Product, Value (USD mn) and Share (%) 44

Figure 16. North America Genome Sequencing Market by Product: Consumables, 2019-2030, USD mn 45

Figure 17. North America Genome Sequencing Market by Product: Sequencers & Software, 2019-2030, USD mn 46

Figure 18. North America Genome Sequencing Market by Product: Service, 2019-2030, USD mn 47

Figure 19. Breakdown of North America Genome Sequencing Market by Technology, 2019-2030, % of Sales Revenue 49

Figure 20. North America Addressable Market Cap in 2021-2030 by Technology, Value (USD mn) and Share (%) 49

Figure 21. North America Genome Sequencing Market by Technology: Polymerase Chain Reaction (PCR), 2019-2030, USD mn 50

Figure 22. North America Genome Sequencing Market by Technology: Sequencing, 2019-2030, USD mn 51

Figure 23. North America Genome Sequencing Market by Technology: Microarray, 2019-2030, USD mn 52

Figure 24. North America Genome Sequencing Market by Technology: Nucleic Acid Extraction and Purification, 2019-2030, USD mn 53

Figure 25. North America Genome Sequencing Market by Technology: Other Technologies, 2019-2030, USD mn 54

Figure 26. Breakdown of North America Genome Sequencing Market by Application, 2019-2030, % of Sales Revenue 56

Figure 27. North America Addressable Market Cap in 2021-2030 by Application, Value (USD mn) and Share (%) 56

Figure 28. North America Genome Sequencing Market by Application: Diagnostics, 2019-2030, USD mn 57

Figure 29. North America Genome Sequencing Market by Diagnostics: Oncology, 2019-2030, USD mn 59

Figure 30. North America Genome Sequencing Market by Diagnostics: Reproductive Health, 2019-2030, USD mn 60

Figure 31. North America Genome Sequencing Market by Diagnostics: Complex Disease Research, 2019-2030, USD mn 61

Figure 32. North America Genome Sequencing Market by Diagnostics: Other Diagnostics, 2019-2030, USD mn 62

Figure 33. North America Genome Sequencing Market by Application: Drug Discovery and Development, 2019-2030, USD mn 63

Figure 34. North America Genome Sequencing Market by Application: Precision Medicine, 2019-2030, USD mn 64

Figure 35. North America Genome Sequencing Market by Application: Agriculture and Animal Research, 2019-2030, USD mn 65

Figure 36. North America Genome Sequencing Market by Application: Other Applications, 2019-2030, USD mn 66

Figure 37. Breakdown of North America Genome Sequencing Market by End User, 2019-2030, % of Revenue 68

Figure 38. North America Addressable Market Cap in 2021-2030 by End User, Value (USD mn) and Share (%) 68

Figure 39. North America Genome Sequencing Market by End User: Academic & Research Centers, 2019-2030, USD mn 69

Figure 40. North America Genome Sequencing Market by End User: Pharmaceutical and Biotechnology Companies, 2019-2030, USD mn 70

Figure 41. North America Genome Sequencing Market by End User: Consumer Genomic Service Providers, 2019-2030, USD mn 71

Figure 42. North America Genome Sequencing Market by End User: Government Institutes, 2019-2030, USD mn 72

Figure 43. North America Genome Sequencing Market by End User: Other End Users, 2019-2030, USD mn 73

Figure 44. Breakdown of North America Genome Sequencing Market by Country, 2019 and 2030, % of Revenue 75

Figure 45. Contribution to North America 2021-2030 Cumulative Market by Country, Value (USD mn) and Share (%) 76

Figure 46. U.S. Genome Sequencing Market, 2019-2030, USD mn 78

Figure 47. Canada Genome Sequencing Market, 2019-2030, USD mn 80

Figure 48. Genome Sequencing Market in Mexico, 2019-2030, USD mn 82

Figure 49. Growth Stage of North America Genome Sequencing Industry over the Forecast Period 84


List Of Table

List of Tables:

 

Table 1. Snapshot of North America Genome Sequencing Market in Balanced Perspective, 2019-2030 17

Table 2. Growth Rate of World GDP, 2020-2022 21

Table 3. World Health Spending by Region, USD bn, 2013-2020 31

Table 4. Main Product Trends and Market Opportunities in North America Genome Sequencing Market 35

Table 5. North America Genome Sequencing Market by Product, 2019-2030, USD mn 43

Table 6. North America Genome Sequencing Market by Technology, 2019-2030, USD mn 48

Table 7. North America Genome Sequencing Market by Application, 2019-2030, USD mn 55

Table 8. North America Genome Sequencing Market: Diagnostics by Type, 2019-2030, USD mn 58

Table 9. North America Genome Sequencing Market by End User, 2019-2030, USD mn 67

Table 10. North America Genome Sequencing Market by Country, 2019-2030, USD mn 75

Table 11. U.S. Genome Sequencing Market by Product, 2019-2030, USD mn 79

Table 12. U.S. Genome Sequencing Market by Application, 2019-2030, USD mn 79

Table 13. U.S. Genome Sequencing Market by End User, 2019-2030, USD mn 79

Table 14. Canada Genome Sequencing Market by Product, 2019-2030, USD mn 81

Table 15. Canada Genome Sequencing Market by Application, 2019-2030, USD mn 81

Table 16. Canada Genome Sequencing Market by End User, 2019-2030, USD mn 81

Table 17. Mexico Genome Sequencing Market by Product, 2019-2030, USD mn 83

Table 18. Mexico Genome Sequencing Market by Application, 2019-2030, USD mn 83

Table 19. Mexico Genome Sequencing Market by End User, 2019-2030, USD mn 83

Table 20. BGI: Company Snapshot 88

Table 21. BGI: Business Segmentation 88

Table 22. BGI: Product Portfolio 89

Table 23. BGI: Revenue, 2018-2020, USD mn 89

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

BGI

Biomatters

Bio-Rad Laboratories, Inc.

DNASTAR

F. Hoffmann-La Roche

Illumina, Inc.

Macrogen Inc.

Myriad Genetics, Inc.

New England Biolabs

Oxford Nanopore Technology

PerkinElmer Inc.

Qiagen

Siemens Healthineers

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Company Profile

Company Profile Title

North America genome sequencing market is projected to grow by 11.5% annually in the forecast period and reach USD 10.77 billion by 2030, driven by the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine.

Highlighted with 23 tables and 49 figures, this 103-page report North America Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America genome sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America genome sequencing market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country.

 

Based on Product, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2019-2030 included in each section.

Consumables

Sequencers & Software

Service

 

Based on Technology, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2019-2030 included in each section.

Polymerase Chain Reaction (PCR)

Sequencing

Microarray

Nucleic Acid Extraction and Purification

Other Technologies

 

Based on Application, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2019-2030 included in each section.

Diagnostics

o Oncology

o Reproductive Health

o Complex Disease Research

o Other Diagnostics

Drug Discovery and Development

Precision Medicine

Agriculture and Animal Research

Other Applications

 

By End User, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2019-2030 included in each section.

Academic & Research Centers

Pharmaceutical and Biotechnology Companies

Consumer Genomic Service Providers

Government Institutes

Other End Users

 

Geographically, the following national/local markets are fully investigated:

U.S.

Canada

Mexico

For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2019-2030. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included.

 

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

BGI

Biomatters

Bio-Rad Laboratories, Inc.

DNASTAR

F. Hoffmann-La Roche

Illumina, Inc.

Macrogen Inc.

Myriad Genetics, Inc.

New England Biolabs

Oxford Nanopore Technology

PerkinElmer Inc.

Qiagen

Siemens Healthineers

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Scope

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 13

1.2.6 Market Size/Share Estimation 14

1.2.7 Research Limitations 15

1.3 Executive Summary 16

2 Market Overview and Dynamics 19

2.1 Market Size and Forecast 19

2.1.1 Impact of COVID-19 on World Economy 20

2.1.2 Impact of COVID-19 on the Market 23

2.2 Major Growth Drivers 25

2.3 Market Restraints and Challenges 32

2.4 Emerging Opportunities and Market Trends 35

2.5 Porter's Fiver Forces Analysis 39

3 Segmentation of North America Market by Product 43

3.1 Market Overview by Product 43

3.2 Consumables 45

3.3 Sequencers & Software 46

3.4 Service 47

4 Segmentation of North America Market by Technology 48

4.1 Market Overview by Technology 48

4.2 Polymerase Chain Reaction (PCR) 50

4.3 Sequencing 51

4.4 Microarray 52

4.5 Nucleic Acid Extraction and Purification 53

4.6 Other Technologies 54

5 Segmentation of North America Market by Application 55

5.1 Market Overview by Application 55

5.2 Diagnostics 57

5.2.1 Oncology 59

5.2.2 Reproductive Health 60

5.2.3 Complex Disease Research 61

5.2.4 Other Diagnostics 62

5.3 Drug Discovery and Development 63

5.4 Precision Medicine 64

5.5 Agriculture and Animal Research 65

5.6 Other Applications 66

6 Segmentation of North America Market by End User 67

6.1 Market Overview by End User 67

6.2 Academic & Research Centers 69

6.3 Pharmaceutical and Biotechnology Companies 70

6.4 Consumer Genomic Service Providers 71

6.5 Government Institutes 72

6.6 Other End Users 73

7 North America Market 2019-2030 by Country 74

7.1 Overview of North America Market 74

7.2 U.S. 77

7.3 Canada 80

7.4 Mexico 82

8 Competitive Landscape 84

8.1 Overview of Key Vendors 84

8.2 New Product Launch, Partnership, Investment, and M&A 87

8.3 Company Profiles 88

BGI 88

Biomatters 90

Bio-Rad Laboratories, Inc. 91

DNASTAR 92

F. Hoffmann-La Roche 93

Illumina, Inc. 94

Macrogen Inc. 95

Myriad Genetics, Inc. 96

New England Biolabs 97

Oxford Nanopore Technology 98

PerkinElmer Inc. 99

Qiagen 100

Siemens Healthineers 101

Thermo Fisher Scientific 102

RELATED REPORTS 103


List Of Figure

List of Figures:

 

Figure 1. Research Method Flow Chart 11

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14

Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16

Figure 4. North America Genome Sequencing Market, 2019-2030, USD mn 19

Figure 5. Impact of COVID-19 on Business 23

Figure 6. Primary Drivers and Impact Factors of North America Genome Sequencing Market 25

Figure 7. World Number of Deaths by Cause in 2017 28

Figure 8. World Number of Deaths from Cancers in 2017 29

Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30

Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 30

Figure 11. Primary Restraints and Impact Factors of North America Genome Sequencing Market 32

Figure 12. Investment Opportunity Analysis 36

Figure 13. Porter's Fiver Forces Analysis of North America Genome Sequencing Market 39

Figure 14. Breakdown of North America Genome Sequencing Market by Product, 2019-2030, % of Revenue 44

Figure 15. North America Addressable Market Cap in 2021-2030 by Product, Value (USD mn) and Share (%) 44

Figure 16. North America Genome Sequencing Market by Product: Consumables, 2019-2030, USD mn 45

Figure 17. North America Genome Sequencing Market by Product: Sequencers & Software, 2019-2030, USD mn 46

Figure 18. North America Genome Sequencing Market by Product: Service, 2019-2030, USD mn 47

Figure 19. Breakdown of North America Genome Sequencing Market by Technology, 2019-2030, % of Sales Revenue 49

Figure 20. North America Addressable Market Cap in 2021-2030 by Technology, Value (USD mn) and Share (%) 49

Figure 21. North America Genome Sequencing Market by Technology: Polymerase Chain Reaction (PCR), 2019-2030, USD mn 50

Figure 22. North America Genome Sequencing Market by Technology: Sequencing, 2019-2030, USD mn 51

Figure 23. North America Genome Sequencing Market by Technology: Microarray, 2019-2030, USD mn 52

Figure 24. North America Genome Sequencing Market by Technology: Nucleic Acid Extraction and Purification, 2019-2030, USD mn 53

Figure 25. North America Genome Sequencing Market by Technology: Other Technologies, 2019-2030, USD mn 54

Figure 26. Breakdown of North America Genome Sequencing Market by Application, 2019-2030, % of Sales Revenue 56

Figure 27. North America Addressable Market Cap in 2021-2030 by Application, Value (USD mn) and Share (%) 56

Figure 28. North America Genome Sequencing Market by Application: Diagnostics, 2019-2030, USD mn 57

Figure 29. North America Genome Sequencing Market by Diagnostics: Oncology, 2019-2030, USD mn 59

Figure 30. North America Genome Sequencing Market by Diagnostics: Reproductive Health, 2019-2030, USD mn 60

Figure 31. North America Genome Sequencing Market by Diagnostics: Complex Disease Research, 2019-2030, USD mn 61

Figure 32. North America Genome Sequencing Market by Diagnostics: Other Diagnostics, 2019-2030, USD mn 62

Figure 33. North America Genome Sequencing Market by Application: Drug Discovery and Development, 2019-2030, USD mn 63

Figure 34. North America Genome Sequencing Market by Application: Precision Medicine, 2019-2030, USD mn 64

Figure 35. North America Genome Sequencing Market by Application: Agriculture and Animal Research, 2019-2030, USD mn 65

Figure 36. North America Genome Sequencing Market by Application: Other Applications, 2019-2030, USD mn 66

Figure 37. Breakdown of North America Genome Sequencing Market by End User, 2019-2030, % of Revenue 68

Figure 38. North America Addressable Market Cap in 2021-2030 by End User, Value (USD mn) and Share (%) 68

Figure 39. North America Genome Sequencing Market by End User: Academic & Research Centers, 2019-2030, USD mn 69

Figure 40. North America Genome Sequencing Market by End User: Pharmaceutical and Biotechnology Companies, 2019-2030, USD mn 70

Figure 41. North America Genome Sequencing Market by End User: Consumer Genomic Service Providers, 2019-2030, USD mn 71

Figure 42. North America Genome Sequencing Market by End User: Government Institutes, 2019-2030, USD mn 72

Figure 43. North America Genome Sequencing Market by End User: Other End Users, 2019-2030, USD mn 73

Figure 44. Breakdown of North America Genome Sequencing Market by Country, 2019 and 2030, % of Revenue 75

Figure 45. Contribution to North America 2021-2030 Cumulative Market by Country, Value (USD mn) and Share (%) 76

Figure 46. U.S. Genome Sequencing Market, 2019-2030, USD mn 78

Figure 47. Canada Genome Sequencing Market, 2019-2030, USD mn 80

Figure 48. Genome Sequencing Market in Mexico, 2019-2030, USD mn 82

Figure 49. Growth Stage of North America Genome Sequencing Industry over the Forecast Period 84


List Of Table

List of Tables:

 

Table 1. Snapshot of North America Genome Sequencing Market in Balanced Perspective, 2019-2030 17

Table 2. Growth Rate of World GDP, 2020-2022 21

Table 3. World Health Spending by Region, USD bn, 2013-2020 31

Table 4. Main Product Trends and Market Opportunities in North America Genome Sequencing Market 35

Table 5. North America Genome Sequencing Market by Product, 2019-2030, USD mn 43

Table 6. North America Genome Sequencing Market by Technology, 2019-2030, USD mn 48

Table 7. North America Genome Sequencing Market by Application, 2019-2030, USD mn 55

Table 8. North America Genome Sequencing Market: Diagnostics by Type, 2019-2030, USD mn 58

Table 9. North America Genome Sequencing Market by End User, 2019-2030, USD mn 67

Table 10. North America Genome Sequencing Market by Country, 2019-2030, USD mn 75

Table 11. U.S. Genome Sequencing Market by Product, 2019-2030, USD mn 79

Table 12. U.S. Genome Sequencing Market by Application, 2019-2030, USD mn 79

Table 13. U.S. Genome Sequencing Market by End User, 2019-2030, USD mn 79

Table 14. Canada Genome Sequencing Market by Product, 2019-2030, USD mn 81

Table 15. Canada Genome Sequencing Market by Application, 2019-2030, USD mn 81

Table 16. Canada Genome Sequencing Market by End User, 2019-2030, USD mn 81

Table 17. Mexico Genome Sequencing Market by Product, 2019-2030, USD mn 83

Table 18. Mexico Genome Sequencing Market by Application, 2019-2030, USD mn 83

Table 19. Mexico Genome Sequencing Market by End User, 2019-2030, USD mn 83

Table 20. BGI: Company Snapshot 88

Table 21. BGI: Business Segmentation 88

Table 22. BGI: Product Portfolio 89

Table 23. BGI: Revenue, 2018-2020, USD mn 89

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

BGI

Biomatters

Bio-Rad Laboratories, Inc.

DNASTAR

F. Hoffmann-La Roche

Illumina, Inc.

Macrogen Inc.

Myriad Genetics, Inc.

New England Biolabs

Oxford Nanopore Technology

PerkinElmer Inc.

Qiagen

Siemens Healthineers

Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)